Cryptococcosis: Clinical Trials

8 trials for Cryptococcosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 28Completed 8
Phase 12Completed 2

Follow Cryptococcosis: new trials by email Literature Review of Cryptococcosis trials Research Report on Cryptococcosis

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimizing the Dose of Flucytosine for the Treatment of Cryptococcal Meningitis
AMBITION trial control, Flucytosine - Cryptococcal Meningitis
Phase 2CompletedUniversity of Minnesota482024-04-092025-08-27
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT)
MAT2203, Amphotericin B - Cryptococcal Meningitis
Phase 1 / Phase 2CompletedMatinas BioPharma Nanotechnologies, Inc.1782019-10-242023-03-31
Treatment With Tamoxifen in Cryptococcal Meningitis
Tamoxifen, Amphotericin B, Fluconazole - Meningitis Streptococcal, Hiv
Phase 2CompletedOxford University Clinical Research Unit, Vietnam502017-10-102019-12-02
High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals
Fluconazole, Amphotericin B - Cryptococcal Meningitis, HIV Infections
Phase 1 / Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1682010-04-162021-11-04
Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis
Amphotericin B, Fluconazole - Cryptococcal Meningitis
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1432005-05-012012-05-16
PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)
Posaconazole oral suspension - Mycoses
Phase 2CompletedMerck Sharp & Dohme LLC982001-01-012015-12-31
Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis
Itraconazole, Flucytosine, Fluconazole - Meningitis, Cryptococcal, HIV Infections
Phase 2CompletedInterMune602000-01-012009-06-03
Dexamethasone in Cryptococcal Meningitis
Flucytosine, Fluconazole, Amphotericin B - Meningitis, Cryptococcal, HIV Infections
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)362021-10-28

Narrower conditions

Meningitis, Cryptococcal (7)  ·  HIV Infections (4)  ·  Meningitis (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  AIDS-Related Opportunistic Infections (1)  ·  Aspergillosis (1)  ·  Bacterial Infections (1)  ·  Brain Diseases (1)  ·  Candidiasis (1)  ·  Invasive Fungal Infections (1)  ·  Meningoencephalitis (1)  ·  Mucormycosis (1)  ·  Mycoses (1)

Broader conditions

Bacterial Infections and Mycoses (8)  ·  Infections (8)  ·  Central Nervous System Diseases (7)  ·  Central Nervous System Fungal Infections (7)  ·  Central Nervous System Infections (7)  ·  Meningitis, Fungal (7)  ·  Mycoses (7)  ·  Nervous System Diseases (7)  ·  Neuroinflammatory Diseases (7)  ·  Blood-Borne Infections (5)  ·  Communicable Diseases (5)  ·  Genital Diseases (5)  ·  Immune System Diseases (5)  ·  Immunologic Deficiency Syndromes (5)

Interventions

Amphotericin B (6)  ·  Fluconazole (5)  ·  Flucytosine (3)  ·  Dexamethasone (1)  ·  Itraconazole (1)  ·  Tamoxifen (1)  ·  amphotericin B, deoxycholate drug combination (1)  ·  interferon gamma-1b (1)  ·  liposomal amphotericin B (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (3)  ·  InterMune (1)  ·  Matinas BioPharma Nanotechnologies, Inc. (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Oxford University Clinical Research Unit, Vietnam (1)  ·  University of Minnesota (1)

Countries

United States (4)  ·  Uganda (3)  ·  Peru (2)  ·  Thailand (2)  ·  India (1)  ·  Kenya (1)  ·  Puerto Rico (1)  ·  South Africa (1)  ·  Vietnam (1)  ·  Zimbabwe (1)

Top investigators

David B Meya (1)  ·  David R Boulware (1)  ·  J Jacobson (1)  ·  Jeremy Day, MD (1)  ·  Robert A. Larsen, MD (1)  ·  Umesh G. Lalloo, MD, FRCP (1)

Results publications

PMID 16436724, PMID 19441980, PMID 19897055, PMID 30801037, PMID 32747357, PMID 34581270, PMID 36780493, PMID 37606364, PMID 38943665, PMID 39972326, PMID 40665233, PMID 40795226